Jane Street
RXRX icon

Jane Street’s Recursion Pharmaceuticals RXRX Stock Holding History

Jane Street’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-125,075
Closed -$483K – 12814
2025
Q4 		$512K Sell
125,075
-596,479
-83% -$2.95M ﹤0.01% 7639
2025
Q3 		$3.52M Buy
+721,554
New +$3.79M ﹤0.01% 3961
2025
Q1 		– Sell
-352,855
Closed -$2.57M – 10448
2024
Q4 		$2.39M Buy
352,855
+114,822
+48% +$772K ﹤0.01% 3808
2024
Q3 		$1.57M Sell
238,033
-337,200
-59% -$2.42M ﹤0.01% 4967
2024
Q2 		$4.31M Buy
575,233
+363,283
+171% +$3.17M ﹤0.01% 3204
2024
Q1 		$2.11M Sell
211,950
-130,711
-38% -$1.46M ﹤0.01% 4031
2023
Q4 		$3.38M Buy
342,661
+307,097
+864% +$2.19M ﹤0.01% 3439
2023
Q3 		$272K Sell
35,564
-69,938
-66% -$698K ﹤0.01% 7202
2023
Q2 		$788K Buy
105,502
+10,531
+11% +$73.7K ﹤0.01% 5606
2023
Q1 		$633K Buy
94,971
+67,878
+251% +$538K ﹤0.01% 5903
2022
Q4 		$209K Sell
27,093
-7,431
-22% -$72.9K ﹤0.01% 7612
2022
Q3 		$367K Buy
34,524
+10,681
+45% +$108K ﹤0.01% 7236
2022
Q2 		$194K Buy
23,843
+9,876
+71% +$66.1K ﹤0.01% 8221
2022
Q1 		$100K Sell
13,967
-4,098
-23% -$43.6K ﹤0.01% 9458
2021
Q4 		$309K Buy
+18,065
New +$340K ﹤0.01% 8112

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street's RXRX Position: Q1 2026 in Review

Jane Street sold out of Recursion Pharmaceuticals (RXRX) in Q1 2026, closing a stake of 125,075 shares — an estimated $483K sold.

Jane Street first reported a position in RXRX in Q4 2021 and held it in 15 quarters. The position peaked at $4.31M in Q2 2024. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Jane Street reported no remaining Recursion Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 125,075 Recursion Pharmaceuticals shares in Q1 2026, an estimated $483K.
  • Jane Street first reported a position in Recursion Pharmaceuticals in Q4 2021 and held it in 15 quarters.
  • Jane Street's Recursion Pharmaceuticals position peaked at $4.31M in Q2 2024.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.